Clinical Trial Update: Therapeutic Control of Aspirin-Exacerbated Respiratory Disease (Aspirin) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial on therapeutic control of aspirin-exacerbated respiratory disease (aspirin-induced asthma) completed with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aspirin-exacerbated Respiratory Disease
• Asthma

Snippet

Sponsor: Elliot Israel, MD | Conditions: Asthma, Aspirin-Induced, Aspirin Exacerbated Asthma | Phase 2 | Status: COMPLETED | Results posted: 2018-07-24